Hanseatic Management Services Inc Aerie Pharmaceuticals Inc Transaction History

Hanseatic Management Services Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 30, 2021	SELL	$15.16 - $18.97 $336,506 - $421,077	-22,197 Closed	0 $0
Q1 2021 May 11, 2021	BUY	$13.12 - $20.9 $291,224 - $463,917	22,197 New	22,197 $397,000
Q1 2018 May 02, 2018	SELL	$51.15 - $61.0 $818 - $976	-16 Closed	0 $0
Q2 2017 Aug 11, 2017	BUY	N/A	16	16 $1,000

2.4M

Ticker AERI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,390,500
Description
Aerie Pharmaceuticals, Inc., a pharmaceutical company, focuses on the discovery, development, and commercialization of ophthalmic therapies for open-angle glaucoma, dry eye, diabetic macular edema, and wet age-related macular degeneration in the United States. Its products include Rhopressa, a once-daily eye drop to reduce elevated intraocular p...

Get notified when there are updates to the investment portfolio of Hanseatic Management Services Inc, based on Form 13F filings with the SEC.

Stay updated on Hanseatic Management Services Inc with notifications on news.